IPO Insights & Analysis
Expert commentary, investment guides and market insights for IPO investors.
14
Articles
Viral Melody Chocolate Trend Sends Wrong “Parle” Stock Into Upper Circuit
Investors mistakenly bought Parle Industries shares after viral Melody chocolate trends, confusing the software company with Parle Products, maker of Parle-G and Melody.
Harikanta Overseas IPO Day 1 Subscription: Muted Start with Weak Retail Interest
Harikanta Overseas IPO records a weak Day 1 subscription of 0.10x, with low retail and HNI participation despite full QIB demand.
Vegorama Punjabi Angithi IPO Subscription Status Day 1: Issue Subscribed 1.45x, Strong NII Demand
Vegorama Punjabi Angithi IPO subscribed 1.45x on Day 1, led by strong HNI demand while QIB participation remains subdued.
NFP Sampoorna Foods IPO Subscription Status Day 3: Issue Subscribed 1.56x, Retail Demand Strong
NFP Sampoorna Foods IPO closes with 1.56x subscription on Day 3, driven by strong retail demand while HNI interest remains weak.
Teamtech Formwork Solutions IPO Subscription Day 2: Weak Demand Continues at 0.57×
Teamtech Formwork Solutions IPO reaches 0.57× subscription on Day 2 with weak demand across categories and zero GMP, signaling cautious investor sentiment.
Global Markets Wobble as Bond Yields Surge; Jio & SpaceX Lead IPO Buzz – May 20, 2026
Sensex dips as 30-year US Treasury yields hit 19-year highs. Flipkart pauses IPO, Muthoot Fincorp plans ₹4,000 Cr issue, and SpaceX eyes a $1.75 trillion valuation. Here's your full market wrap for Ma
Teamtech Formwork Solutions IPO Subscription Day 1: Slow Start with Weak Retail Demand
Teamtech Formwork Solutions IPO opens with a slow Day 1 subscription of 0.33x, showing weak retail and HNI demand despite moderate QIB interest.
Cockroach Janta Party: What the Viral Movement Means for India's Markets
M R Maniveni Foods IPO 2026: GMP, Financials, Risks & Growth Potential Explained
M R Maniveni Foods IPO 2026 is attracting investor attention due to strong revenue growth, rising profits, and expansion plans. Here’s a detailed analysis of GMP, financials, risks, and growth potenti